Indivior Plc said on Wednesday a U.S. court ruling had put a hold on Indian rival Dr. Reddy’s Laboratories launching a generic competitor to the London-listed drugmaker’s bestselling opioid addiction treatment. (Source: Reuters: Health)
Indivior says wins fresh hold on Suboxone copy
Previous post: Dr. Reddy ’s notches win for generic Suboxone sublingual film
Next post: Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder